Philippe Couratier

7PUBLICATIONS
71CO-AUTHORS
Molecular evolutionLegal institutions (incl. courts and justice systems)Pharmaceutical delivery technologiesCancer geneticsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 23, 2026
Bi-allelic intermediate ATXN2 repeat expansions are associated with slow progressing, leg-onset familial ALS.

Koen Cedric Demaegd, Wouter Koole, Joke Jfa van Vugt

|Jun 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALS.

Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews

|Feb 20, 2025
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies.

David Devos, Olivier Rascol, Wassilios G Meissner

|Feb 13, 2025
Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications.

Alfredo Iacoangeli, Allison A Dilliott, Ahmad Al Khleifat

|May 31, 2023
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.

Jeremy M Shefner, Ammar Al-Chalabi, Jinsy A Andrews

Pageof 2